Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
Beta-adrenoblockers, included in any cardiovascular disease treatment standard, became a key part of clinical practice only in late XX century. Nebivolol is a highly selective beta-1 -adrenoiblocker, modulating endothelial NO release and subsequent physiological vasodilatation. Nebivolol has multipl...
保存先:
| 主要な著者: | V. I. Makolkin, D. A. Napalkov |
|---|---|
| フォーマット: | 論文 |
| 言語: | ロシア語 |
| 出版事項: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| シリーズ: | Кардиоваскулярная терапия и профилактика |
| 主題: | |
| オンライン・アクセス: | https://cardiovascular.elpub.ru/jour/article/view/1799 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
著者:: M. L. Maximov
出版事項: (2015-12-01) -
Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
著者:: E. V. Privalova
出版事項: (2007-06-01) -
Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
著者:: O. D. Ostroumova, 等
出版事項: (2011-06-01) -
Differential beta-adrenoblocker therapy in chronic heart failure
著者:: S. N. Tereshchenko, 等
出版事項: (1970-01-01) -
THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
著者:: A. B. Khadzegova
出版事項: (2014-09-01)